Radius Health, which is developing treatments to restore bone density in osteoporosis patients, postponed its IPO on Friday citing poor market conditions. The Cambridge, MA-based company was founded in 2003 and had planned to list on the NASDAQ under the symbol RDUS. Jefferies and Cowen & Company were set to be the joint bookrunners on the deal.
